Table 3.
Comparison of Pros/Cons among imaging modalities.
Pros | Cons | Label | Properties of Measures [98] |
|||
---|---|---|---|---|---|---|
Sensitivity | Spatial Resolution | |||||
Imaging Modality | PET/SPECT | High sensitivity 3D image Quantitative Translational Probe variety Molecular specific Whole body scan Good deep part image |
Facility limitation (RI) Lack of anatomical information (⇒Complementary with CT/MRI) Expensive Half life of nuclide Radiation exposure |
Passive diffusion:89Zr-oxine; 111In-oxine; 99mTc-HMPO Transporter:18FDG Reporter: HSV1-tk/18F-FHBG; NIS/123I |
High | Preclinical PET: ~1 mm Clinical PET: 4–6 mm Preclinical SPECT: 1–2 mm Clinical SPECT: 5–8 mm |
MRI | 3D image Translational Good soft tissue contrast Anatomical information available Good deep part image |
Body motion artifact Low throughput Narrow FOV Expensive |
Negative Contrast Agent: SPIO Positive Contrast Agent:19F, Gd Reporter: Ferritin |
Moderate | Preclinical MRI: 25–250 μm Clinical: 0.5–5 mm, 1–3 mm3 |